Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

BACKGROUND: The implementation of combined radiochemotherapy (RCHT) with temozolomide (TMZ) has lead to a significant increase in overall survival times in patients with Glioblastoma multiforme (GBM), however, outcome still remains unsatisfactory. The majority of GBMs show an overexpression and/or a...

Descripción completa

Detalles Bibliográficos
Autores principales: Combs, Stephanie E, Heeger, Steffen, Haselmann, Renate, Edler, Lutz, Debus, Jürgen, Schulz-Ertner, Daniela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524973/
https://www.ncbi.nlm.nih.gov/pubmed/16709245
http://dx.doi.org/10.1186/1471-2407-6-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524973/
https://www.ncbi.nlm.nih.gov/pubmed/16709245
http://dx.doi.org/10.1186/1471-2407-6-133

Ejemplares similares